Clinical trial

FHND9041 Versus Afatinib for Non-small Cell Lung Cancer

NCT06759857

StatusENROLLING_BY_INVITATION

Study typeINTERVENTIONAL

Start date2021-08-01

PhasePHASE3

Study timeline

Study start (actual)2021-08-01Date precision: day

Registry last updated2025-01-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

FHND9041DRUG

AfatinibDRUG · verified · RxNorm: afatinib

Sponsors & collaborators

Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.lead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06759857 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.